NCT03109262View on ClinicalTrials.gov

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

May 30, 2019

Study Completion Date

February 28, 2021

Conditions
Primary Malignant Liver Neoplasm
Interventions
PROCEDURE

Computed Tomography (CT)

As part of PET/CT and SPECT/CT scans.

PROCEDURE

Positron Emission Tomography (PET)

As part of PET/CT scan

DEVICE

90-Yttrium (Y-90) Glass Microspheres

Radiolabel for PET/CT scan

DIAGNOSTIC_TEST

Technetium 99mTc albumin aggregated (99mTc-MAA)

Radiolabel for 99mTc-MAA SPECT/CT Scan

PROCEDURE

Single-photon emission computerized tomography (SPECT) scan

As part of SPECT/CT scan

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
lead

Stanford University

OTHER

NCT03109262 - Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors | Biotech Hunter | Biotech Hunter